Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-10-26Clinical Trial Update: S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer [Phase 3]
A Phase 3 study (SWOG S0200) comparing carboplatin with or without Doxil in recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer [Phase 1]
Phase 1 study of trebananib (AMG 386) in combination with paclitaxel and carboplatin for ovarian cancer, fallopian tube cancer, and primary …
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer [NA]
This completed clinical trial from Ohio State University Comprehensive Cancer Center evaluated whether stress-reduction interventions can im…
-
CLINICAL_TRIALS trial_result · 2015-08-25Clinical Trial Update: Panitumumab and Gemcitabine in Relapsed Ovarian Cancer [Phase 2]
Phase 2 trial evaluating the combination of panitumumab and gemcitabine in relapsed ovarian, fallopian tube, and primary peritoneal cancers …
-
CLINICAL_TRIALS trial_result · 2015-08-05Clinical Trial Update: Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 3]
This Phase 3 trial evaluated chemotherapy plus surgery for patients with stage III or IV ovarian, fallopian tube, or primary peritoneal canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-08-04Clinical Trial Update: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer [Phase 1]
Phase 1 trial evaluating the combination of carboplatin, gemcitabine hydrochloride, and stereotactic body radiation therapy in gynecologic c…
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 clinical trial evaluating UCN-01 in combination with Topotecan for recurrent, persistent, or progressive advanced ovarian epitheli…
-
CLINICAL_TRIALS trial_result · 2015-07-13Clinical Trial Update: Ixabepilone in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy [Phase 2]
A Phase 2 trial evaluating ixabepilone for ovarian epithelial cancer and primary peritoneal cancer that progressed after prior chemotherapy …
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors [Phase 2]
A Phase 2 trial evaluating consolidation therapy with bevacizumab (Avastin) with or without erlotinib after induction chemotherapy in advanc…
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian [Phase 1]
Phase 1 trial update of neoadjuvant chemotherapy with weekly paclitaxel, carboplatin, and bevacizumab for ovarian and related cancers; study…
-
CLINICAL_TRIALS research · 2015-06-23Clinical Trial Update: DNA Single Nucleotide Polymorphisms as Predictors of Toxicity
The document describes an ongoing clinical trial investigating whether DNA single nucleotide polymorphisms can predict treatment toxicity in…
-
CLINICAL_TRIALS withdrawal · 2015-06-11Clinical Trial Update: Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies [Phase 1, Phase 2]
A Phase 1/2 trial of Tai-chi / Qi-gong for gynecologic cancers has been withdrawn; the study targeted ovarian cancer and primary peritoneal …
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 clinical trial evaluating rhuMab 2C4 with gemcitabine in ovarian, primary peritoneal, and fallopian tube cancers has completed enr…
-
CLINICAL_TRIALS trial_result · 2015-05-25Clinical Trial Update: SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin [Phase 2]
Phase 2 trial of SJG-136 in recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer that failed cisplatin/carboplatin was…
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers [Phase 2]
Phase 2 trial evaluating weekly topotecan with bevacizumab in platinum-resistant/recurrent gynecologic cancers; the study (including ovarian…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with low-dose cyclophosphamide in patients with recurrent ovarian epithelial cancer or primary peritone…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating bevacizumab in patients with persistent or recurrent ovarian epithelial cancer or primary peritoneal cance…
-
CLINICAL_TRIALS trial_result · 2015-05-08Clinical Trial Update: Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 study of polyglutamate paclitaxel in combination with carboplatin for ovarian epithelial, fallopian tube, and primary peritoneal can…
-
CLINICAL_TRIALS research · 2015-05-06Clinical Trial Update: p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer [Phase 2]
This is an update on a Phase 2 clinical trial evaluating a p53 gene therapy for recurrent ovarian epithelial cancer, fallopian tube cancer, …
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer [Phase 2, Phase 3]
A phase 2/3 trial evaluated the combination of saracatinib with paclitaxel in platinum-resistant ovarian cancer, including fallopian tube an…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of gemcitabine, carboplatin, and bevacizumab for ovarian cancer, fallopian tube cancer, or…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor [Phase 2]
Phase 2 clinical trial update evaluating imatinib mesylate in patients with refractory or relapsed ovarian epithelial cancer, fallopian tube…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Immunotoxin Therapy in Treating Patients With Advanced Cancer [Phase 1]
A Phase 1 trial of immunotoxin therapy in patients with advanced cancers has completed, with results spanning several gynecologic and non-gy…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial of an immunotoxin therapy in patients with advanced solid tumors has completed, spanning eight cancer types including cervical…
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer [Phase 2, Phase 3]
Phase 2/3 trial evaluating paclitaxel plus carboplatin with or without SCH-58500 in newly diagnosed stage III ovarian cancer or stage III pr…